David Mountcastle Sells 17,196 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 17,196 shares of the company’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $25.18, for a total transaction of $432,995.28. Following the sale, the chief financial officer directly owned 211,462 shares of the company’s stock, valued at $5,324,613.16. The trade was a 7.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total transaction of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.
• On Thursday, April 2nd, David Mountcastle sold 5,566 shares of Privia Health Group stock. The stock was sold at an average price of $20.85, for a total value of $116,051.10.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $26.88 on Thursday. The stock has a 50-day simple moving average of $23.31 and a two-hundred day simple moving average of $22.98. The firm has a market capitalization of $3.39 billion, a PE ratio of 168.01, a P/E/G ratio of 2.04 and a beta of 0.83. Privia Health Group, Inc. has a 52-week low of $18.77 and a 52-week high of $27.11.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. The firm had revenue of $603.85 million for the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The business’s quarterly revenue was up 25.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.22 EPS. Equities analysts forecast that Privia Health Group, Inc. will post 0.27 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Barclays dropped their price target on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Weiss Ratings cut shares of Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Canaccord Genuity Group dropped their target price on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 8th. Finally, Evercore set a $26.00 price target on Privia Health Group in a research note on Wednesday, April 8th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $31.15.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors have recently added to or reduced their stakes in PRVA. ArrowMark Colorado Holdings LLC purchased a new position in shares of Privia Health Group in the third quarter worth $8,750,000. Royce & Associates LP grew its stake in Privia Health Group by 54.5% during the third quarter. Royce & Associates LP now owns 607,191 shares of the company’s stock valued at $15,119,000 after acquiring an additional 214,166 shares in the last quarter. Renaissance Group LLC bought a new stake in Privia Health Group in the 4th quarter valued at $7,776,000. Principal Financial Group Inc. increased its holdings in Privia Health Group by 1.6% in the 4th quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock valued at $66,099,000 after acquiring an additional 43,589 shares during the last quarter. Finally, Algert Global LLC lifted its stake in Privia Health Group by 277.4% in the 3rd quarter. Algert Global LLC now owns 484,304 shares of the company’s stock worth $12,059,000 after purchasing an additional 355,966 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.